6-4995175-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_006638.4(RPP40):c.995G>A(p.Arg332Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006638.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPP40 | NM_006638.4 | c.995G>A | p.Arg332Gln | missense_variant | 8/8 | ENST00000380051.7 | NP_006629.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPP40 | ENST00000380051.7 | c.995G>A | p.Arg332Gln | missense_variant | 8/8 | 5 | NM_006638.4 | ENSP00000369391 | P1 | |
RPP40 | ENST00000319533.9 | c.926G>A | p.Arg309Gln | missense_variant | 7/7 | 1 | ENSP00000317998 | |||
RPP40 | ENST00000618533.4 | c.869G>A | p.Arg290Gln | missense_variant | 7/7 | 5 | ENSP00000484334 | |||
RPP40 | ENST00000464646.1 | c.815G>A | p.Arg272Gln | missense_variant | 8/8 | 5 | ENSP00000419431 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251444Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135904
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461738Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727194
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74456
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at